Kalkstein Hobart 4
4 · CABOT CORP · Filed Nov 13, 2024
Insider Transaction Report
Form 4
CABOT CORPCBT
Kalkstein Hobart
Executive Vice President
Transactions
- Award
Common Stock
2024-11-08+3,130→ 64,818 total - Exercise/Conversion
Common Stock
2024-11-11$73.84/sh+8,390$619,518→ 59,017 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-11-11−12,178→ 8,119 totalExercise: $58.27Exp: 2031-11-11→ Common Stock (12,178 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2024-11-11−8,390→ 5,594 totalExercise: $73.84Exp: 2032-11-10→ Common Stock (8,390 underlying) - Exercise/Conversion
Common Stock
2024-11-11$58.27/sh+12,178$709,612→ 62,805 total - Sale
Common Stock
2024-11-11$115.54/sh−14,191$1,639,688→ 50,627 total - Sale
Common Stock
2024-11-11$115.00/sh−12,178$1,400,481→ 50,627 total - Sale
Common Stock
2024-11-11$115.02/sh−8,390$965,014→ 50,627 total - Tax Payment
Common Stock
2024-11-12$112.54/sh−2,303$259,180→ 48,324 total - Award
Employee Stock Option (Right to Buy)
2024-11-08+9,341→ 9,341 totalExercise: $114.99Exp: 2034-11-07→ Common Stock (9,341 underlying)
Holdings
- 7,162.738(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.500 to $115.595, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
- [F2]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.000 to $115.040, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $115.000 to $115.325, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the Corporation or any security holder of the Corporation, upon request, full information regarding the number of shares sold at each separate price.
- [F4]The option vests over a three year period as follows: 30% on November 8, 2025, 30% on November 8, 2026 and 40% on November 8, 2027.
- [F5]20,297 shares were subject to the option. The option vested over a three year period as follows: 30% on November 12, 2022, 30% on November 12, 2023 and 40% on November 12, 2024.
- [F6]13,984 shares were subject to the option. The option vested over a three year period as follows: 30% on November 11, 2023, 30% on November 11, 2024 and 40% on November 11, 2025.